Cannabinoid

Aegis Sciences Corporation Announces Expanded Testing for Marijuana

Retrieved on: 
Tuesday, December 5, 2023
Science, Research, Natural Resources, Pharmaceutical, General Health, Health, Cannabis, Other Health, Urine, Mass spectrometry, Cannabinoid, Reflex, Senior, Immunoassay, THC, Airflow Sciences Corporation, Dietary supplement, Aegis, Cannabidiol

Aegis Sciences Corporation , a health care testing lab based in Nashville, Tenn., is pleased to announce it will be updating their urine testing for marijuana and other cannabinoids to include Delta‐8 Carboxy‐THC and Cannabidiol, in addition to Delta‐9 Carboxy‐THC.

Key Points: 
  • Aegis Sciences Corporation , a health care testing lab based in Nashville, Tenn., is pleased to announce it will be updating their urine testing for marijuana and other cannabinoids to include Delta‐8 Carboxy‐THC and Cannabidiol, in addition to Delta‐9 Carboxy‐THC.
  • The interpretation of marijuana results differs when considering presumptive vs definitive testing.
  • Aegis’s assay will continue to undergo presumptive testing by immunoassay with reflex to definitive testing by mass spectrometry.
  • “Expanding our marijuana assay to include other cannabinoids demonstrates our commitment to providing the most relevant testing available to healthcare providers,” said Dr. Rebecca Heltsley, Senior Vice President, Research and Development at Aegis Sciences Corporation.

Organigram Increases Investment in Phylos After Successful Milestone Achievement

Retrieved on: 
Tuesday, November 28, 2023
Professional Services, Cannabis, Retail, Specialty, Finance, Natural Resources, Cannabinoid, Senior, Convertible, Seed, Trailblazer, Loan agreement, Multimedia, THCV, CBDV, OGI, Initial, CBC, PIK, Breeding, R, THCP, Innovation, TSX, Loan, CBG, Security (finance), Organizational chart, Phylo (polychaete), Citrus

This second tranche follows the initial tranche of US$3.25 million advanced in May 2023 for a total of US$6 million in senior secured convertible loans (“Convertible Loans”) currently outstanding.

Key Points: 
  • This second tranche follows the initial tranche of US$3.25 million advanced in May 2023 for a total of US$6 million in senior secured convertible loans (“Convertible Loans”) currently outstanding.
  • View the full release here: https://www.businesswire.com/news/home/20231128416832/en/
    Organigram’s ongoing trials using Phylos technology have resulted in highly-uniform, predictable, and fast-growing seedlings.
  • Our investment in Phylos was driven by that commitment, and we are thrilled with the progress we have made and the benefits we are reaping from this strategic investment,” says Borna Zlamalik, Senior Vice President, R&D and Innovation at Organigram.
  • In August, Organigram launched its first lineup of whole-flower derived THCV products through the Company’s popular SHRED and newly re-launched Trailblazer brands enabled by the strategic investment in Phylos.

Indiva Reports Third Quarter Results Including Record Revenue and Positive Income From Operations

Retrieved on: 
Tuesday, November 21, 2023
Women, Seniors, Cannabis, Men, Specialty, Food, Beverage, Consumer, Retail, Natural Resources, Dark, Cream, Sale, Commitment, Marketing, The Red One, Supply, Analysis, FINANCIAL, POS, Growth, SKU, News, International, Cookie, Limited, Automation, Health Canada, Financial condition report, Result, No Future, EBITDA, Cannabinoid, THC, CBD, Stock, Bank statement, Conversation, Management, The, Research, Q3, Edible, Ageing, CBN, Red One, International Financial Reporting Standards, OCS, Cryptocurrency, Pharmaceutical industry, Video game, Warehouse, Silviculture, Security (finance), Maple syrup, Oil, Indiva, Pearl

"We are delighted to announce the best financial results in Indiva’s corporate history, driven entirely by organic growth, including record net revenue, record gross profit and gross margin, as well as positive EBITDA and positive income from operations.

Key Points: 
  • "We are delighted to announce the best financial results in Indiva’s corporate history, driven entirely by organic growth, including record net revenue, record gross profit and gross margin, as well as positive EBITDA and positive income from operations.
  • Gross revenue in Q3 2023 was a record $10.9 million, representing a 33.7% sequential increase from Q2 2023, and a 23.7% increase year-over-year from Q3 2022.
  • Year-to-date, net revenue increased 6.4% year-over-year to a record $26.7 million.
  • Year-to-date net revenue from edible products increased 0.8% year-over-year to a record $23.2 million or 86.9% of net revenue.

IGC Pharma Reports Second Quarter Fiscal 2024 Results

Retrieved on: 
Monday, November 13, 2023
Agriculture, Natural Resources, Pharmaceutical, Alternative Medicine, Health, Mental Health, Cannabis, Clinical Trials, Composition, Shingles, Fibromyalgia, Cannabinoid, Research, NYSE, Treating, Scleroderma, IND, Epilepsy, Administration, Patient, IGC, Intelligence, Canadian Intellectual Property Office, Agitation, Dementia, LMP, Psoriatic arthritis, Human, Pain, Patent, Pharmaceutical industry, Cryptocurrency

IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the second fiscal quarter of 2024 ended September 30, 2023 (Q2 FY2024).

Key Points: 
  • IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the second fiscal quarter of 2024 ended September 30, 2023 (Q2 FY2024).
  • Revenue in Q2 FY2024 increased 44% to approximately $291,000 compared to the same quarter in FY2023 at roughly $202,000.
  • In the first six months of FY2024, revenue doubled to about $846,000 from about $414,000 compared to the prior year’s six-month period.
  • The Company continues to drive progress with ten sites in the United States and Canada, currently conducting the trial.

New THC Gummies Unveiled by The Hemp Doctor: Kayo Rapid Release and Downshift

Retrieved on: 
Friday, December 15, 2023
Sleep, Cannabinoid, Hemp, Nano, Safety, Hemp oil, Space Delta 9, Edible, THC, Gummy candy, CBN, Delta 8, Energy, THCV, CBC, System, Relaxation, CBG, Pharmaceutical industry, Birth control, Typesetting, Aroma compound, Mineral wool, Gum arabic, D9, CBD, Delta, Nanotechnology

MOORESVILLE, N.C., Dec. 15, 2023 /PRNewswire-PRWeb/ -- Kayo Rapid Release Gummies: Tailored Experiences, Instant Gratification

Key Points: 
  • The Hemp Doctor, a leading name in the CBD industry, is proud to announce the launch of two revolutionary THC gummy products: Kayo Rapid Release and Downshift Gummies.
  • MOORESVILLE, N.C., Dec. 15, 2023 /PRNewswire-PRWeb/ -- Kayo Rapid Release Gummies: Tailored Experiences, Instant Gratification
    Enjoy The Hemp Doctor's Kayo Rapid Release Nano THC Gummies , a ground-breaking product that perfectly balances taste and wellness in each delicious mouthful!
  • Another exciting addition to The Hemp Doctor's product line-up is the improved Downshift Gummies .
  • With Kayo Rapid Release and Downshift Gummies the Hemp Doctor invites consumers to experience a new era of THC gummy excellence.

Rare Cannabinoid Company Launches THC + THCV Uplift Gummies - Unique Edibles With Dreamy Delta-9-THC, Energizing THCV To Combat The Munchies, and CBD Oil

Retrieved on: 
Thursday, December 7, 2023
Emerald, Sleep, Cannabidiol, Interest, Cannabinoid, Hawaii Business, THC, Oil, CBGA, CBDA, Gummy candy, CBN, Exercise, Somnolence, Cannabis, Appetite, CBDV, Coconut oil, CBC, Relaxation, Hunger, Work, Happiness, The Washington Times, Publication, CBG, LA Weekly, MCT, Online shopping, Gasoline, Dam, Perfume, CBD, THCV

HONOLULU, Dec. 7, 2023 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company is thrilled to announce the launch of their groundbreaking product, THC + THCV Uplift Gummies. This new addition to their product line combines the dreamy feel of Delta-9-THC with the energizing, appetite controlling effects of THCV, creating a one-of-a-kind experience for hemp and cannabis enthusiasts.

Key Points: 
  • HONOLULU, Dec. 7, 2023 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company is thrilled to announce the launch of their groundbreaking product, THC + THCV Uplift Gummies .
  • In fact, Rare Cannabinoid Company was the first to create a pure THCV oil tincture and THCV CBD oil in 2020, followed by the strongest THCV gummies on the market.
  • Like their THCV Gummies, Rare Cannabinoid Company's new THC + THCV Gummies boast an impressive 12.5mg of THCV per gummy, the largest amount available in any gummy on the market.
  • Other products with THCV or THC:
    THCV Gummies: For those seeking the energizing, appetite-controlling properties of THCV without any THC effects, Rare Cannabinoid Company also offers THCV gummies with Zero THC.

StickIt Technologies Provides an Update on its Intellectual Property Portfolio

Retrieved on: 
Monday, December 4, 2023
Sale, Canadian Securities Exchange, Cannabinoid, Hemp, Research, HHC, CSE, THC, CBD, Stickit minister, Cannabis, Marketing, Terpene, TEL, News, CBG, Patent, Drug, Czech Republic

TEL AVIV, Israel, Dec. 4, 2023 /PRNewswire/ -- StickIt Technologies Inc. (the "Company" or "StickIt") (CSE: STKT), a parent company of the Israeli technology and cannabinoid company StickIt Ltd., the developer exclusivity and patent protected of "Cannabis Sticks" Technology, is pleased to provide an update with respect to its intellectual property portfolio.

Key Points: 
  • TEL AVIV, Israel, Dec. 4, 2023 /PRNewswire/ -- StickIt Technologies Inc. (the "Company" or "StickIt") (CSE: STKT), a parent company of the Israeli technology and cannabinoid company StickIt Ltd., the developer exclusivity and patent protected of "Cannabis Sticks" Technology, is pleased to provide an update with respect to its intellectual property portfolio.
  • StickIt can be tucked into any smokable including Hemp cigarettes, CBD cigarettes, tobacco cigarettes, pre-rolls, herb cigarettes, spice cigarettes and cannabis smokeballs.
  • StickIt's product come in a wide range of tastes and flavors, as the StickIt technology allows for adding terpenes and to the finished product.
  • Trading in the securities of StickIt should be considered highly speculative and readers should refer to the listing statements of StickIt for further information.

Rare Cannabinoid Company Launches THC + CBG Relief Gummies - The Ultimate Edible for Physical Wellness

Retrieved on: 
Wednesday, November 29, 2023
Sleep, Brain, Cannabinoid, Edible, THC, CBGA, Euphoria, Gummy candy, CBN, Cannabis, Multimedia, Nervous system, Rest, CBDV, CBC, Health, Relaxation, Well-order, CBG, Online shopping, CBD, Cannabigerol

HONOLULU, Nov. 29, 2023 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company, a leading innovator in the world of hemp-based products, is thrilled to announce the launch of its latest creation: THC + CBG Relief Gummies. This groundbreaking edible offers an enticing combination of Delta-9-THC, CBG, and CBD, providing consumers with an all-natural way to support their physical wellness.

Key Points: 
  • HONOLULU, Nov. 29, 2023 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company, a leading innovator in the world of hemp-based products, is thrilled to announce the launch of its latest creation: THC + CBG Relief Gummies .
  • These gummies bring together the best of THC, CBG, and CBD, offering an enjoyable and effective way to support physical wellness."
  • THC + CBG Relief Gummies are the perfect fusion of THC Gummies and CBG Gummies , also with the benefits of CBD.
  • To learn more about THC + CBG Relief Gummies and Rare Cannabinoid Company's other innovative hemp-based products, visit their website.

The Newly Launched Cannabis Brand That Is Already Making News: Say Hello To Elevate

Retrieved on: 
Tuesday, November 28, 2023
Cannabinoid, Elevate, HHC, Delta 8, Delta, CBD, Oil, Drug

Amidst a backdrop of increasing demand and a flood of inferior brands, Elevate is distinguishing itself by setting new standards for product excellence.

Key Points: 
  • Amidst a backdrop of increasing demand and a flood of inferior brands, Elevate is distinguishing itself by setting new standards for product excellence.
  • Elevate, a US-based and licensed cannabis brand, has rapidly gained notoriety for its premium products since its recent inception.
  • Its commitment to quality is resonating with consumers, catapulting the brand into the limelight and attracting a dedicated following in the cannabis community.
  • In the few months since its launch, Elevate has secured headlines in prestigious publications and has been embraced by thousands.

Acannability™ Launches First Periodic Table of Cannabis Molecules Aimed at Mutual Education Between Consumer and Industry Leaders

Retrieved on: 
Tuesday, November 28, 2023
Cannabinoid, Plant, Language, Meta-analysis, Multimedia, Element, Science, Pharmacist, MBA, Terpene, Flavonoid, Chart, Education, Drug

CHICAGO, Nov. 28, 2023 /PRNewswire/ -- Chicago-based Acannability™, a member-driven, direct to consumer cooperative for the cannabis industry, has announced its creation of a first-of-its-kind Cannabis Periodic Table of Molecules™ chart.

Key Points: 
  • CHICAGO, Nov. 28, 2023 /PRNewswire/ -- Chicago-based Acannability™, a member-driven, direct to consumer cooperative for the cannabis industry, has announced its creation of a first-of-its-kind Cannabis Periodic Table of Molecules™ chart.
  • The table, which was created to mirror the original periodic table of elements, features 51 cannabis molecules and precursor acids arranged into four sections representing the entirety of the plant.
  • Development of this groundbreaking tool was led by Acannability™ Scientific Advisor Joseph Friedman, RPh, MBA, a Medical Cannabis Pharmacist and Pharmacology Expert.
  • "The Acannability™ table was developed to empower consumers with scientific facts of the plants ingredients," states Friedman.